Jeffrey Low - Andreessen Horowitz

Latest Posts

Disruptive Innovation: The Role of Hospitals, Integration, and the Value-Added Process

by Jeffrey Low, Richard Menger, and Gregory Mundis

a16z Podcast: Shifting Risk Mindsets, From Tech to Bio

with Jorge Conde, Vijay Pande, and Jeffrey Low

a16z Video: Shifting Risk Mindsets, from Tech to Bio

by Jorge Conde, Vijay Pande, and Jeffrey Low

16 Pitfalls to Avoid When Building a Computational Therapeutics Company

by Jeffrey Low, Vijay Pande, and Jorge Conde

From @JeffreyLowMD

Jeffrey Low@JeffreyLowMD

JPM Tips 1 Later first meeting start 2 Fewer, longer, higher quality meetings of preferentially of non-SF, Boston people 3 Leave open space. Serendipitous add will be >10x better than the marginal schedule 4 Max 2 parties per time slot 5 Distinctive umbrella to avoid party mixups https://t.co/RX5DRZucg7

Jeffrey Low@JeffreyLowMD

The most substantive drug pricing/biotech VC article I've read in a while @LifeSciVC 1 New pricing proposals will affect innovation 2 Generics a major boon to society 3 Need for value based pricing and expansion of generic competition esp in biologics https://t.co/54B8pxW3IA

Jeffrey Low@JeffreyLowMD

Congrats to the @CTRLlabsCo team. Crazy progress from the first jumble of wires demo I saw years ago. https://t.co/8G3MUbSjjS